Smartstockz

[december]

SAN DIEGO (AP) -- Drug developer Avanir Pharmaceuticals said it will
receive a $5 million payment from British drug maker AstraZeneca PLC
now that an early stage clinical trial on a novel cholesterol drug
has started.
The agreement between the companies, which began in July with a $10
million upfront payment, entitles Avanir to up to $330 million in
milestone payments for the development of a reverse cholesterol
transport drug that pulls cholesterol from tissues and into the
liver
where it can be transported to the gall bladder and out of the body.

The $5 million payment was the first milestone received under the
agreement.

http://wwww.avanir.com

http://www.xenerex.com

Just Out!, Avanir Submits NDA For Priority Review w/ FDA!!!!!
HUGE!!!!